ACG: Compliance Reduces Inhospital Stay in Crohn’s (CME/CE)

SAN ANTONIO (MedPage Today) — Crohn’s disease patients who were more adherent to their prescribed injections of the anti-tumor necrosis factor infliximab spent less time in the hospital for disease flares than less adherent patients, researchers said here.

Post a Comment

Comments are closed.